日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer

体重指数对乳腺癌患者新辅助化疗疗效的预测价值

期刊:Breast Care
影响因子:2.1
doi:10.1159/000526732
Emirzeoglu, Levent; Arici, Serdar; Sahin, Ahmet Bilgehan; Ocak, Birol; Ak, Naziye; Ay, Seval; Mammadov, Elkhan; Turna, Hande; Bilici, Ahmet
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Prognostic value of expression levels of miR-148a, miR-152 and HLA-G in colon cancer

miR-148a、miR-152及HLA-G表达水平对结肠癌预后的价值

期刊:Oncology Letters
影响因子:2.5
doi:10.3892/ol.2022.13347
Levent Emirzeoglu, Ozgur Olmez, Fatma Nihan Akkoc Mustafayev, Ufuk Berber, Ismail Yilmaz, Serkan Celik, Bala Basak Oven, Mehmet Alpaslan Ozgun
肿瘤
肠癌
发表日期：2022
文献求助 收藏

ALK‑positive locally advanced lung cancer in a patient who achieved long‑term complete response with crizotinib: A case report

ALK阳性局部晚期肺癌患者使用克唑替尼获得长期完全缓解：病例报告

期刊:
影响因子:
doi:10.3892/etm.2022.11587
Emirzeoglu, Levent; Olmez, Ozgur
肺癌
肿瘤
肿瘤免疫
ALK
发表日期：2022
文献求助 收藏

Malignant melanoma and papillary thyroid carcinoma that were diagnosed concurrently and treated simultaneously: A case report

同时诊断并同时治疗的恶性黑色素瘤和乳头状甲状腺癌：病例报告

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2014.2642
Ozgun, Alpaslan; Tuncel, Tolga; Emirzeoglu, Levent; Celik, Serkan; Bilgi, Oguz; Haholu, Abdullah; Urhan, Muammer; Karagoz, Bulent
黑色素瘤
肿瘤
肿瘤免疫
甲状腺癌
免疫/内分泌
发表日期：2015
文献求助 收藏

Immunoregulatory function of HLA-G in gastric cancer

HLA-G在胃癌中的免疫调节功能

期刊:Asian Pacific Journal of Cancer Prevention
影响因子:
doi:10.7314/apjcp.2013.14.12.7681
Tolga Tuncel, Bulent Karagoz, Aptullah Haholu, Alpaslan Ozgun, Levent Emirzeoglu, Oguz Bilgi, Emin Gokhan Kandemir
肿瘤
胃癌
发表日期：2013
文献求助 收藏

Epidemiological characteristics of patients who died of cancer in the Haydarpasa Training Hospital, Istanbul

伊斯坦布尔海达尔帕夏培训医院癌症死亡患者的流行病学特征

期刊:Croatian Medical Journal
影响因子:2.3
doi:10.3325/cmj.2012.53.645
Ozgun, Alpaslan; Tuncel, Tolga; Emirzeoglu, Levent; Bilgi, Oguz; Karagoz, Bulent
肿瘤
肿瘤免疫
发表日期：2012
文献求助 收藏